U.Y. Fincorp Limited Approves Rs 187.17 Crore Preferential Issue

U.Y. Fincorp Limited approved a proposed Rs 187.17 crore preferential issue on November 2, 2026, covering 5,21,20,000 equity shares and 2,45,90,000 convertible warrants priced at Rs 24.40 each. The board decision starts an approval process rather than a completed issuance, with shareholder and regulatory or statutory clearances still required.

What did U.Y. Fincorp approve on November 2, 2026?

U.Y. Fincorp approved the proposed issue of equity shares and convertible equity warrants through a preferential route at its board meeting on November 2, 2026. The aggregate stated amount is Rs 187.1724 crore, comprising Rs 127.1728 crore through direct equity shares and Rs 59.9996 crore through warrants.

The company proposed issuing up to 5,21,20,000 equity shares and up to 2,45,90,000 warrants. Both securities have a face value of Rs 5 each and an issue price of Rs 24.40 per unit, which includes a premium of Rs 19.40 per share or warrant.

The announcement is an approval for a proposed fund raise, not evidence that securities have been allotted. U.Y. Fincorp said the transaction remains subject to shareholder approval and applicable regulatory or statutory approvals.

How is the proposed Rs 187.17 crore issue structured?

U.Y. Fincorp has split the proposed issue between an immediate equity-share component and a warrant component that may become equity later. The direct share issue is proposed for 136 investors, while all warrants are proposed for three subscribers.

The proposed allotment schedules represent maximum proposed quantities. They do not establish a completed transaction, final post-issue shareholding, or the date when any shares or warrants will be allotted.

The direct equity-share component would add shares to the capital base if allotted. The warrant component represents a potential future addition to equity, because warrant holders must convert their warrants for the related equity shares to be issued.

When can the warrants be converted into equity shares?

Each U.Y. Fincorp warrant can be converted into one equity share at any time within 18 months from the warrant allotment date. The conversion can take place in one or more tranches during that period.

If all 2,45,90,000 warrants are converted, the company would issue an equal number of additional equity shares. However, the supplied disclosure does not provide an allotment date, so the start of the 18-month conversion window has not been disclosed.

The distinction matters for investors assessing the capital structure. Direct shares, if allotted, become outstanding equity immediately, whereas the effect of warrants on the share count depends on their eventual conversion within the permitted period.

What approvals must U.Y. Fincorp obtain before allotment?

U.Y. Fincorp must obtain shareholder approval and relevant regulatory or statutory approvals before the proposed issue can proceed. The company said the issuance will be made under Chapter V of the Securities and Exchange Board of India Issue of Capital and Disclosure Requirements Regulations, 2018, the Companies Act, 2013, and applicable rules.

The board also approved a notice to convene an Extraordinary General Meeting, or EGM. The disclosure does not specify the EGM date, the voting outcome, or the timing of any regulatory or statutory approvals.

These steps are material because board approval alone does not result in an allotment. Investors will need subsequent company disclosures to confirm shareholder approval, the final allotment of shares and warrants, and any changes to the company’s share capital.

How could the proposal affect U.Y. Fincorp shareholders?

The proposed issue could increase U.Y. Fincorp's outstanding equity capital if the direct equity shares are allotted and if the warrants are later converted. Existing shareholders' percentage ownership may therefore be diluted, although the supplied information does not provide the current outstanding share count or a quantified dilution estimate.

The proposal does not include a disclosed market-price reaction, an EGM outcome, or an allotment confirmation. As a result, the available information supports an assessment of the proposed securities and approvals, but not a conclusion on final ownership changes or the completed fund raise.

The Rs 24.40 issue price is uniform across both components. The share issue accounts for about two-thirds of the stated fund-raising amount, while the warrant issue accounts for the remaining amount and may enter the equity base over the conversion period.

Conclusion

U.Y. Fincorp has approved a proposed Rs 187.17 crore preferential issue with 5,21,20,000 equity shares and 2,45,90,000 convertible warrants, all priced at Rs 24.40. The structure combines a direct equity component for 136 investors with warrants for three subscribers, creating the possibility of additional equity issuance over time.

The next disclosed step is the EGM notice approved by the board. Investors should watch for the meeting date, shareholder approval, regulatory or statutory clearances, allotment details, and the warrant allotment date that would begin the 18-month conversion period.